And again PR from Medify is quiet, and market takes it as they have nothing good to say at this point. If this is continue to be the case we can see much low prices from now on.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.